| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |